Interfacial Ligand Engineering Breaks the Activity-Selectivity Trade-Off in Electrochemical Alkynol Semihydrogenation and -Deuteration
Journal of the American Chemical Society · 05.08.2026 · 148 (30) · 32916-32924
DOI: 10.1021/jacs.6c13582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.07.2026. Verfasst von Xingzhou Zha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Ultrafine Materials of Ministry of Education, School of Chemical Engineering, East China University of Science and Technology, Sha…. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Electrochemical alkynol semihydrogenation and -deuteration uses water as the hydrogen source, offering a green alternative to thermocatalytic routes. However, its potential is constrained by an inherent activity-selectivity trade-off. Here, we demonstrate an interfacial ligand engineering strategy to break this seesaw effect. Through theoretical and experimental screening, cysteine, featuring both a thiol group and hydrophilic moieties, is identified as the optimal ligand. The cysteine-modified Cu (Cu-Cys) interface achieves concurrent gains in selectivity, conversion rate, and energy efficiency in electrochemical alkynol semihydrogenation and -deuteration. Using the electrochemical semihydrogenation of 2-methyl-3-butyn-2-ol (MBY) to 2-methyl-3-buten-2-ol (MBE) as a representative case, mechanistic studies reveal that the adsorbed cysteine ligands promote interfacial water transfer and dissociation to generate reactive hydrogen for boosting MBY semihydrogenation, while the thiol-mediated Cu surface facilitates MBE desorption and inhibits overhydrogenation, collectively accounting for the simultaneous enhancement in both conversion and selectivity. To demonstrate the practical potential, a flow cell incorporating the Cu-Cys catalyst exhibits stable performance for over 1000 h. The Cu-Cys catalyst compared to bare Cu reduces the power consumption for MBE electrosynthesis from ∼4.55 to ∼3.63 kWh kg–1. Furthermore, a customized scaled-up electrolysis system equipped with a 400 cm2 Cu-Cys electrode delivers near-complete MBY conversion while maintaining over 90% MBE selectivity at an applied current of 40 A.
Autor:innen und Institutionen
- Key Laboratory for Ultrafine Materials of Ministry of Education, School of Chemical Engineering, East China University of Science and Technology, Shanghai200237, China.
- Shanghai Engineering Research Center of Hierarchical Nanomaterials, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai200237, China.
- Department of Chemical Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai200240, China.
ORCID-Profile: Hongliang Jiang, Chunzhong Li
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zha, X., Tang, L., Zhao, Y., Ge, W., Jiang, H., & Li, C. (2026). Interfacial Ligand Engineering Breaks the Activity-Selectivity Trade-Off in Electrochemical Alkynol Semihydrogenation and -Deuteration. Journal of the American Chemical Society, 148(30), 32916-32924. https://doi.org/10.1021/jacs.6c13582
Vancouver
Zha X, Tang L, Zhao Y, Ge W, Jiang H, Li C. Interfacial Ligand Engineering Breaks the Activity-Selectivity Trade-Off in Electrochemical Alkynol Semihydrogenation and -Deuteration. Journal of the American Chemical Society. 2026;148(30):32916-32924. doi:10.1021/jacs.6c13582
BibTeX
@article{Zha2026,
author = {Zha, Xingzhou and Tang, Lei and Zhao, Yuan and Ge, Wangxin and Jiang, Hongliang and Li, Chunzhong},
title = {Interfacial Ligand Engineering Breaks the Activity-Selectivity Trade-Off in Electrochemical Alkynol Semihydrogenation and -Deuteration},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {30},
pages = {32916--32924},
doi = {10.1021/jacs.6c13582}
}
EUVIMED